BOD — Bod Science Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Bod Science, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.899 | 1.52 | 1.53 | 2.93 | 1.62 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.83 | -4.18 | -5.68 | -0.914 | 0.937 |
| Capital Expenditures | -0.019 | -0.019 | -0.069 | -0.014 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.008 | -0.188 | -0.22 | -1.92 | -0.275 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.027 | -0.207 | -0.29 | -1.94 | -0.275 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.5 | 0 | 4.14 | 0.765 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.67 | -4.39 | -1.63 | -2.06 | 0.663 |